What are the primary recommendations for a patient with chronic obstructive pulmonary disease (COPD) undergoing hospice recertification?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hospice Recertification SOAP Note for COPD Patient

Subjective

Document continued terminal prognosis with life expectancy ≤6 months if disease follows natural course. 1 The patient must demonstrate progressive decline despite optimal therapy, severe functional impairment, and increasing healthcare utilization to meet recertification criteria. 1

Key Elements to Document:

  • Dyspnea severity: Disabling dyspnea at rest, poorly responsive to bronchodilators, with decreased functional capacity 1
  • Functional decline: Inability to perform activities of daily living, increasing dependence on caregivers 1
  • Recent healthcare utilization: Document emergency department visits or hospitalizations for pulmonary infections and/or respiratory failure since last certification 1
  • Symptom burden: Assess dyspnea, pain, anxiety, depression, fatigue, poor nutrition, cough, and insomnia 2, 3
  • Patient/family understanding: Confirm DNR/DNI status and understanding that hospice provides comfort care only 1

Objective

Required Clinical Indicators:

  • Pulmonary function: FEV1 <30% predicted (post-bronchodilator) 1
  • Gas exchange abnormalities:
    • Hypoxemia at rest on supplemental oxygen: PaO2 ≤55 mmHg or SaO2 ≤88% 1
    • Hypercapnia: PaCO2 ≥50 mmHg 1
  • Cardiac complications: Right heart failure secondary to pulmonary disease (cor pulmonale) 1
  • Vital signs: Document respiratory rate, oxygen saturation, heart rate, blood pressure
  • Physical examination findings: Accessory muscle use, pursed-lip breathing, cyanosis, peripheral edema, cachexia 4
  • Weight: Document unintentional weight loss if present 2

Functional Status:

  • Performance status: Document Karnofsky or Palliative Performance Scale score
  • ADL dependence: Specify assistance needed for bathing, dressing, toileting, transfers, eating 1

Assessment

Patient continues to meet hospice eligibility criteria for end-stage COPD with terminal prognosis. 1 The physician certifying hospice eligibility certifies that prognosis is more likely than not less than 6 months if disease runs its natural course, not a "guarantee" of death within 6 months. 1

Clinical Justification:

  • Progressive disease despite optimal medical management including [specify current medications] 1
  • Severe airflow obstruction with FEV1 <30% predicted 1
  • Persistent hypoxemia/hypercapnia despite supplemental oxygen 1
  • Recurrent exacerbations requiring [number] hospitalizations/ED visits in past [timeframe] 1
  • Cor pulmonale present [if applicable] 1
  • Severe functional impairment with dependence in [number] ADLs 1

Symptom Assessment:

  • Dyspnea: [Severity and impact on function] 2
  • Pain: [Location, severity, current management] 2
  • Anxiety/Depression: [Presence and severity] 2
  • Other symptoms: Fatigue, cough, insomnia, poor appetite 2, 3

Plan

Symptom Management:

  • Continue supplemental oxygen for comfort, not to prolong life 1
  • Bronchodilators: Continue current regimen for symptom relief 2
  • Opioids: [Specify dose/frequency] for refractory dyspnea 2, 3
  • Anxiolytics: [Specify medication] for anxiety/panic if present 2
  • Other medications: Address pain, depression, insomnia as needed 2, 3

Interdisciplinary Team Involvement:

  • Registered nurse: Regular visits to assess symptom control, functional status, and caregiver needs 1
  • Social worker: Provide psychosocial support to patient and family 1
  • Chaplain: Spiritual support as desired 1
  • Home health aide: Assistance with personal care 1

Advance Care Planning:

  • DNR/DNI status confirmed: [Document current status] 1
  • Preferences for future exacerbations: Patient/family understand no hospitalization for acute events, comfort measures only 1
  • Preferred place of death: [Document if discussed] 2

Monitoring:

  • Hospice nurse visits [specify frequency] to reassess symptoms and adjust medications 1
  • Physician availability for urgent symptom management 1
  • 24/7 on-call support for patient/family 1

Common Pitfalls to Avoid:

  • Do not delay palliative interventions waiting for absolute certainty of 6-month prognosis—COPD trajectory is unpredictable 2, 4
  • Do not overlook depression and anxiety, which are common and treatable in advanced COPD 2
  • Do not continue disease-modifying therapies that no longer align with comfort-focused goals 2
  • Ensure reliable oxygen delivery system is in place to prevent distressing hypoxemia 1

Recertification period: [Specify 60 or 90 days per Medicare guidelines]

Next physician evaluation: [Date within required timeframe]

References

Guideline

Hospice Recertification for End-Stage COPD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the treatment for acute Chronic Obstructive Pulmonary Disease (COPD)?
What are the treatment options for an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD)?
What is the best course of treatment for a female adult patient with a history of Chronic Obstructive Pulmonary Disease (COPD) experiencing worsening hypercapnia?
What is the approach to managing Chronic Obstructive Pulmonary Disease (COPD) exacerbation?
What is the best course of action for a 68-year-old patient with shortness of breath (SOB), a history of chronic obstructive pulmonary disease (COPD) with emphysema, currently taking inhaled corticosteroid (ICS), long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and using albuterol and ipratropium nebulizers, with recent leukocytosis and impaired renal function, following two COPD exacerbations in the past month?
Is a dose of 8 to 10 micrograms (µg) per kilogram of body weight significant or very significant for a patient, considering factors such as past medical history, age, weight, and potential substance use?
What are the monitoring and management strategies for a patient with risk factors such as diabetes, hypertension, or a family history of kidney disease, regarding their estimated Glomerular Filtration Rate (eGFR)?
What is leukocyte (white blood cell) esterase and its significance in a patient, particularly in those with a history of urinary tract infections (UTIs), diabetes, or impaired renal function?
What is the best treatment approach for a patient with calcific tendinosis of the rotator cuff and biceps tenosynovitis, possibly with underlying comorbidities like diabetes?
Is back surgery (including procedures 22853, 22551, and 20930) medically necessary for a 56-year-old female patient with cervical radiculopathy, who has a history of previous cervical surgery, and presents with neck and left arm pain, numbness, and weakness, despite conservative treatments with acetaminophen and diclofenac?
What is the recommended treatment and dosage of Suboxone (buprenorphine/naloxone) for a patient with opioid use disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.